Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune landscapes in patients with gastric adenocarcinoma

被引:0
|
作者
Hong, Haidu [1 ]
Huang, Yuancheng [2 ,3 ]
Yang, Zehong [4 ]
Jiang, Xiaotao [4 ]
Liu, Hong [5 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Southern Med Univ, Dongguan Peoples Hosp, Dept Oncol, Affiliated Hosp 10, Dongguan 523000, Guangdong, Peoples R China
[3] Southern Med Univ, Dongguan Peoples Hosp, Canc Ctr, Affiliated Hosp 10, Dongguan 523000, Guangdong, Peoples R China
[4] Guangzhou Univ Chinese Med, Clin Med Coll 1, Guangzhou 510405, Guangdong, Peoples R China
[5] Guangdong Pharmaceut Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Gonghexiheng St 1, Guangzhou 510080, Guangdong, Peoples R China
关键词
Gastric adenocarcinoma; Pyroptosis; Long non-coding RNAs; Prognostic signature; Tumor microenvironment; Immunotherapy; NONCODING RNAS; EXPRESSION;
D O I
10.1007/s12672-024-01579-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectivesThe purpose of this study was to investigate the significance of pyroptosis-related lncRNAs (PRlncRNA) in predicting prognoses and immune landscapes of patients with gastric adenocarcinoma (STAD).MethodsTranscriptomic data and clinicopathological data were obtained from The Cancer Genome Atlas database. Based on correlation analysis and univariate Cox regression, prognostic PRlncRNA were identified. Subsequently, a PRlncRNA prognostic signature (PRLPS) was generated via least absolute shrinkage and selection operator (LASSO) regression, Kaplan-Meier method, receiver operating characteristic (ROC) curves, principal component analysis, and univariate and multivariate regression. Besides, the clinicopathological characteristics, tumor microenvironment (TME) scores, the immune landscapes in different risk subgroups were explored. Moreover, based on three PRlncRNA, we constructed a competing endogenous RNA (ceRNA) network. Additionally, Gene Set Enrichment Analysis (GSEA), Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) and Gene Ontology (GO) analysis were performed for biological functional analysis based on the difference between high- and low- risk groups, which also used to screen out potential STAD drugs.Results21 PRlncRNA made up the prognostic signature, which had significant value in predicting the overall survival (OS), clinicopathological features, TME, immune checkpoint genes expression, and the response to immune checkpoint inhibitors of patients with STAD. In a addition, we constructed a ceRNA network comprising 3 PRlncRNAs and 69 mRNAs. The function of PRlncRNA was related to cancer-associated pathways. Ten small molecular drugs that might improve the prognosis of patients were screened out by connectivity maps.ConclusionsUsing PRlncRNA as a prognostic indicator for STAD, we identified predictive biomarkers and immunotherapy targets while refreshing our understanding.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
    Liu, Jinhui
    Geng, Rui
    Ni, Senmiao
    Cai, Lixin
    Yang, Sheng
    Shao, Fang
    Bai, Jianling
    MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 27 : 1036 - 1055
  • [2] m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
    Xu, Feng
    Huang, Xiaoling
    Li, Yangyi
    Chen, Yongsong
    Lin, Ling
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 24 : 780 - 791
  • [3] Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
    Liang, Deku
    Hu, Min
    Tang, Qin
    Huang, Mao
    Tang, Liangdan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 8073 - 8085
  • [4] A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma
    Xia, Fada
    Yan, Yuanliang
    Shen, Cong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [5] N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
    Zhang, He
    Kong, Weimin
    Zhao, Xiaoling
    Han, Chao
    Liu, Tingting
    Li, Jing
    Song, Dan
    BMC GENOMIC DATA, 2022, 23 (01):
  • [6] N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
    He Zhang
    Weimin Kong
    Xiaoling Zhao
    Chao Han
    Tingting Liu
    Jing Li
    Dan Song
    BMC Genomic Data, 23
  • [7] Constructing and Validating a Pyroptosis-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival
    Xu, Jingmin
    Chen, Ke
    Wei, Zhou
    Wu, Zixuan
    Huang, Xuyan
    Cai, Minjie
    Yuan, Kai
    Huang, Peidong
    Zhang, Jing
    Wang, Shuai
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [8] Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer
    Yang, Xia
    Weng, Xin
    Yang, Yajie
    Jiang, ZhiNong
    FRONTIERS IN GENETICS, 2022, 12
  • [9] Fatty Acid Metabolism-Related lncRNAs are Potential Biomarkers for Predicting Prognoses and Immune Responses in Patients with Skin Cutaneous Melanoma
    Wang, Xing
    Yang, Xiaojing
    Zhang, Yiming
    Guo, Afei
    Luo, Suju
    Xiao, Meng
    Xue, Lu
    Zhang, Guohui
    Wang, Huiping
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3595 - 3614
  • [10] Pyroptosis-Related Signature as Potential Biomarkers for Predicting Prognosis and Therapy Response in Colorectal Cancer Patients
    Li, Zhiyong
    Liu, Yang
    Lin, Baiqiang
    Yan, Wei
    Yi, Huijie
    Wang, Haoran
    Wei, Yunwei
    FRONTIERS IN GENETICS, 2022, 13